Smallpox (Vaccinia) Vaccine, Live
(Source: What's New at CBER)
Source: What's New at CBER - March 1, 2018 Category: Biomedical Science Source Type: news
Pneumococcal Vaccine, Polyvalent
(Source: What's New at CBER)
Source: What's New at CBER - February 27, 2018 Category: Biomedical Science Source Type: news
Gamunex-C
(Source: What's New at CBER)
Source: What's New at CBER - February 26, 2018 Category: Biomedical Science Source Type: news
Flebogamma DIF 5% & 10%
Updated Package Insert, December 2009. (Source: What's New at CBER)
Source: What's New at CBER - February 26, 2018 Category: Biomedical Science Source Type: news
DigiFab
Product approval information is indicated for Treatment of patients with life-threatening or potentially life-threatening digoxin toxicity or overdose. (Source: What's New at CBER)
Source: What's New at CBER - February 23, 2018 Category: Biomedical Science Source Type: news
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
(Source: What's New at CBER)
Source: What's New at CBER - February 21, 2018 Category: Biomedical Science Source Type: news
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
(Source: What's New at CBER)
Source: What's New at CBER - February 21, 2018 Category: Biomedical Science Source Type: news
Alphanate
(Source: What's New at CBER)
Source: What's New at CBER - February 15, 2018 Category: Biomedical Science Source Type: news
Advate
(Source: What's New at CBER)
Source: What's New at CBER - February 15, 2018 Category: Biomedical Science Source Type: news
Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry
This is the Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry. (Source: What's New at CBER)
Source: What's New at CBER - February 14, 2018 Category: Biomedical Science Source Type: news
NovoSevenRT
(Source: What's New at CBER)
Source: What's New at CBER - February 14, 2018 Category: Biomedical Science Source Type: news
NovoSeven
(Source: What's New at CBER)
Source: What's New at CBER - February 14, 2018 Category: Biomedical Science Source Type: news
Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2018
Guidance agenda outling guidance documents CBER is planning to publish during calendar year 2018. (Source: What's New at CBER)
Source: What's New at CBER - January 19, 2018 Category: Biomedical Science Source Type: news
Guidance for Industry: BLA for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System
This is the Guidance for Industry: BLA for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System. (Source: What's New at CBER)
Source: What's New at CBER - January 5, 2018 Category: Biomedical Science Source Type: news
Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271 - Guidance for Industry
Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271 Guidance for Industry. (Source: What's New at CBER)
Source: What's New at CBER - January 5, 2018 Category: Biomedical Science Source Type: news
